TREVOR SPURLING: Open Payments
NPI 1255040564 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 36 payments from 13 companies in 2025. Trend: 2023 $324 · 2024 $1,172 · 2025 $771
Food & beverage: $720Education: $51
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $203 |
| ABBVIE INC. | 10 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $135 |
| Lilly USA, LLC | 2 | $48 |
| PFIZER INC. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $27 |
| Braintree Laboratories, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
Products named: TREMFYA, RINVOQ, ENTYVIO, EOHILIA, OMVOH, XELJANZ, LINZESS, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
